About Us
Overview
Our Business
Board of Directors
Executive Leadership Team
Our Stories
Biocon Biologics Malaysia
Scientific Publications
Awards & Recognition
Our Legacy
Business
Global Biosimilars Portfolio
Oncology
Immunology
Diabetology
Ophthalmology
Bone Health & Others
Our Products
Global
India
Partners
Global Footprint
Capabilities
Research & Development
Quality & Compliance
Global Scale Manufacturing
Commitment
Investors
News
Press Releases
Company Statements
Our Stories
Media Contacts
Careers
Working With Us
Now Hiring
Contact Us
Biocon Biologics and Viatris Receive European Commission Approval for Kixelle, Biosimilar Insulin Aspart
Thu, 11-Feb-2021
Posted by: Biocon Biologics
No Comments
Author:
Biocon Biologics